A246720 Stock Overview

Engages in the development of diagnosis solutions in South Korea. More details

A246720 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Revenue has declined by 12.7% over the past year

Latest financial reports are more than a year old

Shareholders have been diluted in the past year

Does not have a meaningful market cap (₩61B)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

ASTA Corporation Competitors

DRGEM

KOSDAQ:A263690

₩60.5b

MiCo BioMed

KOSDAQ:A214610

₩63.9b

Corentec

KOSDAQ:A104540

₩69.3b

Genoray

KOSDAQ:A122310

₩73.3b

Price History & Performance

Summary of share price highs, lows and changes for ASTA
Historical stock prices
Current Share Price	₩4,480.00
52 Week High	₩7,520.00
52 Week Low	₩3,910.00
Beta	1.16
1 Month Change	-6.08%
3 Month Change	-13.01%
1 Year Change	-34.31%
3 Year Change	-2.29%
5 Year Change	-7.63%
Change since IPO	-64.44%

Recent updates

We Think ASTA (KOSDAQ:246720) Can Afford To Drive Business Growth

Mar 30

Companies Like ASTA (KOSDAQ:246720) Are In A Position To Invest In Growth

Dec 15

Shareholder Returns

	A246720	KR Medical Equipment	KR Market
7D	-3.8%	-3.2%	-3.7%
1Y	-34.3%	-3.0%	-10.4%

Return vs Industry: A246720 underperformed the KR Medical Equipment industry which returned -3.1% over the past year.

Return vs Market: A246720 underperformed the KR Market which returned -10.4% over the past year.

Price Volatility

Is A246720's price volatile compared to industry and market?
A246720 volatility
A246720 Average Weekly Movement	6.8%
Medical Equipment Industry Average Movement	7.4%
Market Average Movement	6.6%
10% most volatile stocks in KR Market	12.7%
10% least volatile stocks in KR Market	3.3%

Stable Share Price: A246720 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A246720's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2006	29	Eung-Jun Cho	www.astams.com

ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also iprovides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such as cancer and degenerative brain diseases; OASys, an laser desorption ionization time of flight mass spectrometer for OLED analysis and test; MALDI Plate, a disposable plate; and rapid enzyme digestion system.

ASTA Corporation Fundamentals Summary

How do ASTA's earnings and revenue compare to its market cap?
A246720 fundamental statistics
Market cap	₩60.78b
Earnings (TTM)	-₩2.88b
Revenue (TTM)	₩3.39b

17.9x

P/S Ratio

-21.1x

P/E Ratio

Is A246720 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A246720 income statement (TTM)
Revenue	₩3.39b
Cost of Revenue	₩1.87b
Gross Profit	₩1.52b
Other Expenses	₩4.40b
Earnings	-₩2.88b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-212.11
Gross Margin	44.91%
Net Profit Margin	-84.94%
Debt/Equity Ratio	0%

How did A246720 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 15:59
End of Day Share Price	2024/12/20 00:00
Earnings	2023/09/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ASTA Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution